Bedaquiline-A new drug against multidrug-resistant tuberculosis Yadav Sankalp1,*, Rawal Gautam2 1General Duty Medical Officer-II, Dept. of Medicine & TB, Chest Clinic Moti Nagar, North Delhi Municipal Corporation, New Delhi 2Associate Consultant, Dept. of Respiratory Intensive Care, Max Super Speciality Hospital, New Delhi, India *Corresponding Author: Email: drsankalpyadav@gmail.com
Online published on 3 January, 2019. Abstract The infectious diseases have taken a toll on the rapidly multiplying population of the developing countries. The top three killers being HIV AIDS, TB and malaria. The total number of deaths due to TB is really a cause of concern since a well laid national program is running in most of these countries. However, even in the presence of clear guidelines to treat TB, there has always been a gradual rise in the new cases with few exceptions in some of these resource-constrained countries. The issue becomes graver when the problem of drug-resistant TB also comes into the picture. In the present article, the authors highlight the introduction of the new drug i.e., Bedaquiline in India to counter the problem of multidrug-resistant TB. Top Keywords Bedaquiline, Drug; Drug-resistant, TB, Tuberculosis. Top |